The North America Endoluminal Suturing Devices Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).
Endoluminal suturing devices provide a higher rate of recovery and meet consumer demand for noninvasive medical procedures, which improves patient experience and results in quicker recovery times, fewer hospital visits, and shorter hospital stays. The acceptability of endoluminal suturing devices has also been aided by the use of sophisticated tools. The primary drivers propelling the growth of the endoluminal suturing devices market are the increasing prevalence of obesity and chronic diseases that create patient pools, as well as the rising demand for less invasive operations.
Obesity has become a pandemic, a serious health risk, and the second-most preventable cause of death in the United States. Endoluminal surgery meets the need of patients for minimally invasive procedures that are carried out in a hollow organ employing suturing and stapling surgical techniques.
Endoluminal surgeries are becoming more popular as people become more aware of the advantages of minimally invasive techniques and the drop in post-operative problems. These elements might help to explain why the market for endoluminal suturing devices is expanding. Increase in the number of suturing procedures, the aging population, and technological advancements in the production of suturing devices.
Since non-emergency treatments have been severely curtailed or postponed due to coronavirus disease 2019 (COVID-19) for almost two months now, doctors and health care authorities are concerned about Canada's rising backlog of urgent surgery. The World Health Organization estimates that between 20 and 50 million people experienced treatable injuries in February 2020, including bone fractures, and underwent successful ankle arthroplasty and other bone procedures.
The US market dominated the North America Endoluminal Suturing Devices Market by Country in 2021; thereby, achieving a market value of $42.9 million by 2028. The Canada market is estimated to grow at a CAGR of 13.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 12.9% during (2022 - 2028).
Based on Application, the market is segmented into Gastrointestinal Surgery, Bariatric Surgery, Gastroesophageal Reflux Disease Surgery and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Endoluminal Suturing Devices Market is Predict to reach $152.3 Million by 2028, at a CAGR of 12%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apollo Endosurgery, Inc., Johnson & Johnson, Medtronic PLC, Cook Medical, Inc. (Cook Group), USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics S.A., ErgoSuture, Suture Ltd.
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
